In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients
Anna M. Jermakowicz, Luz Clarita Ruiz, Jonathan Chu, Nitish Jangde, Robert K. Suter, Nina S. Kadan‐Lottick, Derek J. Hanson, Nagi G. Ayad
This paper develops DrugSeq, a computational platform that predicts drug sensitivities in medulloblastoma subgroups, identifying subgroup-specific therapies and potential drug repositioning candidates.
Scientific Reports · Nov 27, 2025Peer-reviewedCancer Biology